Skip to content
CancerIndex

Publication

Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.

Authors not recorded

Cancer Res1999PMID 10485475stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (3)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 3

Curated evidence

Evidence citing this paper (2)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
10485475
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–2 of 2 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
KIT Exon 11 Mutation2
(diagnostic)Gastrointestinal Stromal TumorDiagnosticBSupports Positive2accepted
EID225

KIT mutation is associated with larger, more invasive tumors, greater pathologic histology and older patients compared to tumors with wildtype KIT.

PMID 10485475 · Taniguchi et al., 1999 · Open in CIViC

civic
(prognostic)Gastrointestinal Stromal TumorPrognosticBSupports Poor Outcome3accepted
EID376

KIT mutation is associated with worse overall and cause-specific prognosis in patients with GIST compared to patients with wildtype KIT.

PMID 10485475 · Taniguchi et al., 1999 · Open in CIViC

civic